SE470477B - Salva innehållande fibronektin för behandling av sår - Google Patents

Salva innehållande fibronektin för behandling av sår

Info

Publication number: SE470477B
Authority: SE; Sweden
Prior art keywords: weight; ointment; ointment according; wound; mixture
Prior art date: 1992-10-05

Application number

SE9202895A

Other languages

English (en)

Swedish (sv)

Other versions

SE9202895D0 (sv

SE9202895L (sv

Inventor

Per E Alm

Pia Alm

Original Assignee

Procell Bioteknik Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-05

Filing date

1992-10-05

Publication date

1994-05-24

1992-10-05 Publication of SE9202895D0 publication Critical patent/SE9202895D0/xx

1992-10-05 Priority to SE9202895A priority Critical patent/SE470477B/sv

1992-10-05 Application filed by Procell Bioteknik Ab filed Critical Procell Bioteknik Ab

1993-09-21 Priority to ES93850180T priority patent/ES2146223T3/es

1993-09-21 Priority to AT93850180T priority patent/ATE190500T1/de

1993-09-21 Priority to EP93850180A priority patent/EP0592380B1/de

1993-09-21 Priority to DE69328065T priority patent/DE69328065T2/de

1993-10-01 Priority to AU48801/93A priority patent/AU4880193A/en

1993-10-04 Priority to US08/131,149 priority patent/US5733870A/en

1993-10-04 Priority to CA002107598A priority patent/CA2107598A1/en

1993-10-05 Priority to JP24948193A priority patent/JP3715659B2/ja

1994-04-06 Publication of SE9202895L publication Critical patent/SE9202895L/

1994-05-24 Publication of SE470477B publication Critical patent/SE470477B/sv

Links

239000002674 ointment Substances 0.000 title claims abstract description 34
108010067306 Fibronectins Proteins 0.000 title claims abstract description 14
102000016359 Fibronectins Human genes 0.000 title claims abstract description 14
206010052428 Wound Diseases 0.000 title claims description 18
208000027418 Wounds and injury Diseases 0.000 title claims description 18
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 6
229920000136 polysorbate Polymers 0.000 claims abstract description 6
OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 6
229950008882 polysorbate Drugs 0.000 claims abstract description 5
241001465754 Metazoa Species 0.000 claims abstract description 4
241000894007 species Species 0.000 claims abstract description 3
239000000203 mixture Substances 0.000 claims description 10
239000003871 white petrolatum Substances 0.000 claims description 9
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 8
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
238000009835 boiling Methods 0.000 claims description 4
229960000541 cetyl alcohol Drugs 0.000 claims description 4
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 4
229940012831 stearyl alcohol Drugs 0.000 claims description 4
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims description 3
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims description 3
229940057995 liquid paraffin Drugs 0.000 claims description 3
230000007935 neutral effect Effects 0.000 claims description 3
WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 claims description 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
229930003316 Vitamin D Natural products 0.000 claims description 2
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 2
235000012239 silicon dioxide Nutrition 0.000 claims description 2
229940075554 sorbate Drugs 0.000 claims description 2
229930003231 vitamin Natural products 0.000 claims description 2
239000011782 vitamin Substances 0.000 claims description 2
229940088594 vitamin Drugs 0.000 claims description 2
235000013343 vitamin Nutrition 0.000 claims description 2
235000019155 vitamin A Nutrition 0.000 claims description 2
239000011719 vitamin A Substances 0.000 claims description 2
235000019166 vitamin D Nutrition 0.000 claims description 2
239000011710 vitamin D Substances 0.000 claims description 2
150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
229940045997 vitamin a Drugs 0.000 claims description 2
229940046008 vitamin d Drugs 0.000 claims description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
206010072170 Skin wound Diseases 0.000 claims 1
239000002243 precursor Substances 0.000 claims 1
230000009841 epithelial lesion Effects 0.000 abstract 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
230000035876 healing Effects 0.000 description 6
230000000694 effects Effects 0.000 description 5
229940067003 orabase Drugs 0.000 description 4
230000029663 wound healing Effects 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000012188 paraffin wax Substances 0.000 description 3
235000019271 petrolatum Nutrition 0.000 description 3
101001027553 Bos taurus Fibronectin Proteins 0.000 description 2
241000283086 Equidae Species 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
241000282414 Homo sapiens Species 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
229940003587 aquaphor Drugs 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000000499 gel Substances 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
238000000034 method Methods 0.000 description 2
239000003921 oil Substances 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
MTZBBNMLMNBNJL-UHFFFAOYSA-N xipamide Chemical compound CC1=CC=CC(C)=C1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1O MTZBBNMLMNBNJL-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 1
101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
229920001219 Polysorbate 40 Polymers 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
230000000337 effect on mastitis Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
VEJWJJHJBSJZGF-UHFFFAOYSA-N formaldehyde;2-hydroxy-4-methylbenzenesulfonic acid Chemical compound O=C.CC1=CC=C(S(O)(=O)=O)C(O)=C1 VEJWJJHJBSJZGF-UHFFFAOYSA-N 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
210000000003 hoof Anatomy 0.000 description 1
239000003906 humectant Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002690 local anesthesia Methods 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
210000002445 nipple Anatomy 0.000 description 1
239000003883 ointment base Substances 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
229940101027 polysorbate 40 Drugs 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
239000001993 wax Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE9202895A 1992-10-05 1992-10-05 Salva innehållande fibronektin för behandling av sår SE470477B (sv)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
SE9202895A SE470477B (sv)	1992-10-05	1992-10-05	Salva innehållande fibronektin för behandling av sår
ES93850180T ES2146223T3 (es)	1992-10-05	1993-09-21	Unguento que contiene fibronectina para el tratamiento de lesiones epiteliales.
AT93850180T ATE190500T1 (de)	1992-10-05	1993-09-21	Fibronektin enthaltende salbe zur behandlung von epithelialen verletzungen
EP93850180A EP0592380B1 (de)	1992-10-05	1993-09-21	Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen
DE69328065T DE69328065T2 (de)	1992-10-05	1993-09-21	Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen
AU48801/93A AU4880193A (en)	1992-10-05	1993-10-01	Ointment for treatment of epithelial lesions
CA002107598A CA2107598A1 (en)	1992-10-05	1993-10-04	Ointment for treatment of epithelial lesions
US08/131,149 US5733870A (en)	1992-10-05	1993-10-04	Ointment for treatment of epithelial lesions
JP24948193A JP3715659B2 (ja)	1992-10-05	1993-10-05	上皮病巣の治療用軟膏

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9202895A SE470477B (sv)	1992-10-05	1992-10-05	Salva innehållande fibronektin för behandling av sår

Publications (3)

Publication Number	Publication Date
SE9202895D0 SE9202895D0 (sv)	1992-10-05
SE9202895L SE9202895L (sv)	1994-04-06
SE470477B true SE470477B (sv)	1994-05-24

Family

ID=20387373

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9202895A SE470477B (sv)	1992-10-05	1992-10-05	Salva innehållande fibronektin för behandling av sår

Country Status (9)

Country	Link
US (1)	US5733870A (de)
EP (1)	EP0592380B1 (de)
JP (1)	JP3715659B2 (de)
AT (1)	ATE190500T1 (de)
AU (1)	AU4880193A (de)
CA (1)	CA2107598A1 (de)
DE (1)	DE69328065T2 (de)
ES (1)	ES2146223T3 (de)
SE (1)	SE470477B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
GB9705340D0 (en) *	1997-03-14	1997-04-30	Nycomed Imaging As	Compositions
FR2777461B1 (fr) *	1998-04-16	2003-04-25	Ceetal Sa Lab	Agent de soin du trayon et procede de preparation
US6917095B1 (en)	2000-05-30	2005-07-12	Altera Corporation	Integrated radio frequency circuits
JP4313033B2 (ja) *	2002-12-27	2009-08-12	株式会社日本点眼薬研究所	眼科用治療組成物
US20050014730A1 (en) *	2003-04-02	2005-01-20	Carlson Robert M.	Anti-fungal formulation of triterpene and essential oil

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4017615A (en) *	1970-10-29	1977-04-12	Syntex Corporation	Propylene carbonate ointment vehicle
JPS5976007A (ja) *	1982-10-22	1984-04-28	Shiseido Co Ltd	化粧料
DE3426903A1 (de) *	1984-07-20	1986-01-23	Biotest Pharma GmbH, 6000 Frankfurt	Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
JPS61103836A (ja) *	1984-10-24	1986-05-22	Green Cross Corp:The	フイブロネクチン製剤
JPS62123112A (ja) *	1985-11-22	1987-06-04	Sunstar Inc	軟膏基剤
FI854634A0 (fi) *	1985-11-22	1985-11-22	Labsystems Oy	Foerfarande foer bestaemning av proteolytisk aktivitet.
US4837019A (en) *	1986-08-11	1989-06-06	Charles Of The Ritz Group Ltd.	Skin treatment composition and method for treating burned skin
US4929442A (en) *	1986-09-26	1990-05-29	Exovir, Inc.	Compositions suitable for human topical application including a growth factor and/or related materials
US5036056A (en) *	1987-07-08	1991-07-30	Martin Kludas	Methods for treating damaged corneal, uterine, or cartilage tissue
US5246708A (en) *	1987-10-28	1993-09-21	Pro-Neuron, Inc.	Methods for promoting wound healing with deoxyribonucleosides
US5053388A (en) *	1987-11-09	1991-10-01	Chiron Ophthalmics, Inc.	Wound healing composition and method
US5055298A (en) *	1987-12-01	1991-10-08	Chemisches Laboratorium Dr. Kurt Richter Gmbh	Cosmetic composition comprising an extracellular connective tissue matrix
US4939135A (en) *	1988-10-03	1990-07-03	Alcon Laboratories, Inc.	Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5196185A (en) *	1989-09-11	1993-03-23	Micro-Collagen Pharmaceutics, Ltd.	Collagen-based wound dressing and method for applying same
JP3088744B2 (ja) *	1990-05-28	2000-09-18	日本ケミカルリサーチ株式会社	フィブロネクチン組成物

1992
- 1992-10-05 SE SE9202895A patent/SE470477B/sv not_active IP Right Cessation
1993
- 1993-09-21 ES ES93850180T patent/ES2146223T3/es not_active Expired - Lifetime
- 1993-09-21 AT AT93850180T patent/ATE190500T1/de not_active IP Right Cessation
- 1993-09-21 EP EP93850180A patent/EP0592380B1/de not_active Expired - Lifetime
- 1993-09-21 DE DE69328065T patent/DE69328065T2/de not_active Expired - Lifetime
- 1993-10-01 AU AU48801/93A patent/AU4880193A/en not_active Abandoned
- 1993-10-04 CA CA002107598A patent/CA2107598A1/en not_active Abandoned
- 1993-10-04 US US08/131,149 patent/US5733870A/en not_active Expired - Fee Related
- 1993-10-05 JP JP24948193A patent/JP3715659B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP3715659B2 (ja)	2005-11-09
SE9202895D0 (sv)	1992-10-05
CA2107598A1 (en)	1994-04-06
EP0592380A1 (de)	1994-04-13
ES2146223T3 (es)	2000-08-01
SE9202895L (sv)	1994-04-06
US5733870A (en)	1998-03-31
DE69328065T2 (de)	2000-11-02
JPH06199684A (ja)	1994-07-19
EP0592380B1 (de)	2000-03-15
AU4880193A (en)	1994-04-21
DE69328065D1 (de)	2000-04-20
ATE190500T1 (de)	2000-04-15

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 9202895-0

Format of ref document f/p: F

2012-12-04

NUG

Patent has lapsed

Publication	Publication Date	Title
Michanek et al.	1989	Intestinal transmission of macromolecules in newborn dairy calves of different ages at first feeding
DE1810438A1 (de)	1969-07-10	Prophylaktisches oder therapeutisches Praeparat
SE470477B (sv)	1994-05-24	Salva innehållande fibronektin för behandling av sår
DE60038106T3 (de)	2011-06-01	Anthelmintische zusammensetzungen
JPH0629161B2 (ja)	1994-04-20	殺外部寄生虫製剤、その製造法および外部寄生虫の防除法
Gutzwiller	2002	Effect of colostrum intake on diarrhoea incidence in new-born calves
SE453259B (sv)	1988-01-25	Kosmetiskt preparat med formaga till aterbildning av hud- och muskelvevnad
GB2274988A (en)	1994-08-17	Iodine containing wound-healing preparations
US4466959A (en)	1984-08-21	Preparation for udder care and disinfection for dairy animals
AU2006207326B2 (en)	2011-04-14	Anthelmintic composition
EP0336433B1 (de)	1994-02-02	Pflanzenschutzmittel
SU1629064A1 (ru)	1991-02-23	Средство дл профилактики мастита у животных
Herd et al.	1965	Prevention of hypomagnesaemia and grass tetany
CN108670948A (zh)	2018-10-19	一种纳米级微囊单分子聚维酮碘溶液及其制备方法
HU198843B (en)	1989-12-28	Process for producing veterinary compositions with disinfecting and antiinflammatory action, comprising natural active ingredient and suitable particularly for treating mastitis
US4282253A (en)	1981-08-04	Topical prophylaxis against schistosomiasis
DE2537203A1 (de)	1976-03-04	Sedatives praeparat
GB2195082A (en)	1988-03-30	Veterinary solutions of thiamphenicol
Høgh et al.	1961	Tracer Dye Green S (Food Green No. 4) in Penicillin Preparations For Intra-Mammary Application, Ii.
RU2055579C1 (ru)	1996-03-10	Препарат для профилактики и лечения эндометритов у коров
Jones et al.	1962	Vitamin A studies in the dairy calf
JPH1149672A (ja)	1999-02-23	創傷治療用外用剤
McHardy et al.	1980	Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride
Round	1968	Experiences with thiabendazole as an anthelmintic for horses
GB2200845A (en)	1988-08-17	Teat-treating composition